Virtu Financial LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2022$477,000
+31.0%
6,284
+42.9%
0.04%
+63.0%
Q1 2022$364,000
+0.8%
4,399
-8.5%
0.03%
-27.0%
Q4 2021$361,000
-72.2%
4,808
-17.8%
0.04%
-70.6%
Q2 2021$1,297,000
+197.5%
5,846
+77.2%
0.13%
+306.5%
Q1 2021$436,000
-21.9%
3,299
-34.2%
0.03%
-67.7%
Q3 2020$558,000
-56.4%
5,013
-75.2%
0.10%
+28.0%
Q2 2019$1,280,00020,2450.08%
Other shareholders
NOVOCURE LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$39,681,00020.12%
HARTLINE INVESTMENT CORP/ 330,672$27,866,0005.97%
MORGAN JESS S & CO INC 52,889$4,457,0004.37%
Darsana Capital Partners LP 1,350,000$113,765,0003.88%
Rhenman & Partners Asset Management AB 350,000$29,495,0003.23%
COURAGE CAPITAL MANAGEMENT LLC 10,000$843,0002.55%
Taylor Frigon Capital Management LLC 38,073$3,208,0002.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,500$2,991,0001.08%
Granite Investment Partners, LLC 261,315$22,021,0001.04%
Nicholas Investment Partners, LP 85,835$7,233,0000.74%
View complete list of NOVOCURE LTD shareholders